Title : C-type natriuretic peptide inhibits thrombin- and angiotensin II-stimulated endothelin release via cyclic guanosine 3',5'-monophosphate.

Pub. Date : 1992 Apr

PMID : 1313393






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 C-type natriuretic peptide inhibits thrombin- and angiotensin II-stimulated endothelin release via cyclic guanosine 3",5"-monophosphate. Cyclic GMP natriuretic peptide C Homo sapiens
2 In addition, CNP potently increased the cellular level of cyclic guanosine 3",5"-monophosphate (GMP), with the inhibition of immunoreactive endothelin-1 secretion in response to thrombin and Ang II being paralleled by the increase in the cyclic GMP level. Cyclic GMP natriuretic peptide C Homo sapiens
3 In addition, CNP potently increased the cellular level of cyclic guanosine 3",5"-monophosphate (GMP), with the inhibition of immunoreactive endothelin-1 secretion in response to thrombin and Ang II being paralleled by the increase in the cyclic GMP level. Cyclic GMP natriuretic peptide C Homo sapiens
4 In addition, CNP potently increased the cellular level of cyclic guanosine 3",5"-monophosphate (GMP), with the inhibition of immunoreactive endothelin-1 secretion in response to thrombin and Ang II being paralleled by the increase in the cyclic GMP level. Cyclic GMP natriuretic peptide C Homo sapiens
5 The increase of cyclic GMP produced by CNP was also greater than that due to porcine ANP(1-28) or porcine BNP-26. Cyclic GMP natriuretic peptide C Homo sapiens
6 Our results suggest that CNP probably inhibits the endothelin-1 secretion stimulated by thrombin and Ang II through a cyclic GMP-dependent process. Cyclic GMP natriuretic peptide C Homo sapiens
7 The increase of cyclic GMP levels and the inhibition of immunoreactive endothelin-1 secretion produced by CNP appear to be greater than those produced by ANP or BNP. Cyclic GMP natriuretic peptide C Homo sapiens